Literature DB >> 16476427

First look at the effect of overexpression of TIGR/MYOC on the transcriptome of the human trabecular meshwork.

Teresa Borrás1, Paul A Bryant, Sarah S Chisolm.   

Abstract

Wild-type TIGR/MYOC is a secreted protein implicated in the development of steroid glaucoma. Mutations in TIGR/MYOC have been linked to some patients who develop elevated intraocular pressure (IOP) and glaucoma. Because there is evidence of some other factors contributing to the TIGR/MYOC causative role in glaucoma, and because substantial increased levels of a particular cellular mRNA and protein might alter expression of other host genes, we began to investigate the effect of TIGR/MYOC overexpression on the transcriptome of human trabecular meshwork cells. We used a recombinant adenovirus carrying wild-type TIGR/MYOC cDNA, primary HTM cells, 300 viral particles per cell and U133 Affymetrix GeneChips. Our results indicate that 2361 out of the 22,284 genes (10.6%) were altered more than two-fold (p<or=0.005) by the overexpression of TIGR/MYOC. A higher proportion of the altered genes were downregulated (1412 vs. 949). Potentially relevant upregulated genes include angiopoietin 2, matrix metalloproteinase 1 (MMP1) and thrombomodulin; among those downregulated we observed growth arrest specific 1, proteins involved in the ubiquitination pathway and vascular cell adhesion molecule 1. In addition, collagen type 1, one of the MMP1 substrates, was also downregulated. Genes affected by wild-type TIGR/MYOC might prove to be candidate mediators for future studies of the mechanisms of glaucoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16476427     DOI: 10.1016/j.exer.2005.11.005

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  7 in total

1.  Individual molecular response to elevated intraocular pressure in perfused postmortem human eyes.

Authors:  Núria Comes; Teresa Borrás
Journal:  Physiol Genomics       Date:  2009-04-28       Impact factor: 3.107

Review 2.  The effects of myocilin expression on functionally relevant trabecular meshwork genes: a mini-review.

Authors:  Teresa Borrás
Journal:  J Ocul Pharmacol Ther       Date:  2014-02-24       Impact factor: 2.671

3.  Development of a gene therapy virus with a glucocorticoid-inducible MMP1 for the treatment of steroid glaucoma.

Authors:  Maria-Grazia Spiga; Teresa Borrás
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-20       Impact factor: 4.799

4.  Elevated amounts of myocilin in the aqueous humor of transgenic mice cause significant changes in ocular gene expression.

Authors:  Walter Paper; Markus Kroeber; Sebastian Heersink; Dietrich A Stephan; Rudolf Fuchshofer; Paul Russell; Ernst R Tamm
Journal:  Exp Eye Res       Date:  2008-06-17       Impact factor: 3.467

5.  Cystatin a, a potential common link for mutant myocilin causative glaucoma.

Authors:  K David Kennedy; S A AnithaChristy; Lakisha K Buie; Teresa Borrás
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

6.  Effect of immunomodulation with anti-CD40L antibody on adenoviral-mediated transgene expression in mouse anterior segment.

Authors:  J Cameron Millar; Iok-Hou Pang; Wan-Heng Wang; Yu Wang; Abbot F Clark
Journal:  Mol Vis       Date:  2008-01-09       Impact factor: 2.367

7.  sCD44 overexpression increases intraocular pressure and aqueous outflow resistance.

Authors:  Michael Giovingo; Michael Nolan; Ryan McCarty; Iok-Hou Pang; Abbot F Clark; Rachel M Beverley; Steven Schwartz; W Daniel Stamer; Loyal Walker; Algis Grybauskas; Kevin Skuran; Paulius V Kuprys; Beatrice Y J T Yue; Paul A Knepper
Journal:  Mol Vis       Date:  2013-11-01       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.